French Data Reassure on Bivalent COVID Booster and Stroke Risk

(MedPage Today) -- Cardiovascular events were not more likely for recipients of the Pfizer-BioNTech COVID-19 mRNA bivalent booster compared with the original monovalent booster, according to French researchers. Their population-based study found...
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news